Global insulin manufacturers saw revenues of $34 billion in 2017-2018, projected to rise to $44 billion in 2021. Before he was recently named by Donald Trump as secretary of health, Alex Azar made $2 million last year as CEO of Eli Lilly, and then got a $1.6 million severance package. The current CEO, David Ricks, stands to make close to $12 million by the end of his first year at Lilly, according the Indiana Business Journal.